MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to tame deadly transplant complication
Disease control Recruiting nowThis phase 3 trial compares two drug combinations given after a stem cell transplant to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. The study will enroll 572 adults with blood cancers like leukemia or myelodysplasi…
Matched conditions: MYELODYSPLASIA
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 23, 2026 22:04 UTC
-
New drug cocktail aims to stop deadly transplant complication
Disease control Recruiting nowThis phase 2 trial tests whether adding ruxolitinib to standard drugs (cyclophosphamide and tacrolimus) can prevent severe graft-versus-host disease (GVHD) in 124 adults with blood cancers like leukemia. Participants receive a stem cell transplant after high-dose chemotherapy, th…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Hannah Choe, MD • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New stem cell transplant aims to cut dangerous side effects in blood cancer patients
Disease control Recruiting nowThis study tests a special stem cell transplant for children and adults with blood cancers like leukemia. The transplant uses stem cells that have had certain immune cells removed to lower the risk of graft-versus-host disease, a serious complication. About 70 participants will r…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New stem cell transplant method aims to cut complications in young blood cancer patients
Disease control Recruiting nowThis pilot study tests a stem cell transplant method that removes specific immune cells (alpha/beta T cells and B cells) from the donor cells before transplant. The goal is to reduce the risk of graft-versus-host disease, a serious complication, while still allowing the transplan…
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
Blood antibody test may pinpoint autoimmune platelet disorder
Knowledge-focused Recruiting nowThis study looks at whether a specific blood test (MAIPA) can identify anti-platelet antibodies to confirm autoimmune thrombocytopenia (ITP) at diagnosis. Researchers will enroll 225 adults with low platelet counts and compare antibody results with final diagnoses. The goal is to…
Matched conditions: MYELODYSPLASIA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:57 UTC